|
ATP11B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.666000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.586800E-01 |
| Normal-vs-Stage2 |
8.224600E-01 |
| Normal-vs-Stage3 |
9.709600E-01 |
| Normal-vs-Stage4 |
6.600000E-01 |
| Stage1-vs-Stage2 |
9.257200E-01 |
| Stage1-vs-Stage3 |
7.680200E-01 |
| Stage1-vs-Stage4 |
5.867800E-01 |
| Stage2-vs-Stage3 |
8.786000E-01 |
| Stage2-vs-Stage4 |
6.213600E-01 |
| Stage3-vs-Stage4 |
6.606400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.743400E-01 |
| Normal-vs-AfricanAmerican |
8.414400E-01 |
| Normal-vs-Asian |
6.130000E-01 |
| Caucasian-vs-AfricanAmerican |
8.768000E-01 |
| Caucasian-vs-Asian |
8.094800E-01 |
| AfricanAmerican-vs-Asian |
7.243600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.595420E-01 |
| Normal-vs-Female |
4.095200E-03 |
| Male-vs-Female |
2.644700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.527200E-01 |
| Normal-vs-Extreme_Weight |
1.343790E-01 |
| Normal-vs-Obese |
4.161400E-01 |
| Normal-vs-Extreme_Obese |
8.141600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.558600E-01 |
| Normal_Weight-vs-Obese |
4.017800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.646400E-01 |
| Extreme_Weight-vs-Obese |
5.475600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.282000E-01 |
| Obese-vs-Extreme_Obese |
5.443600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.014800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.316230E-01 |
| Normal-vs-Age(61-80Yrs) |
1.829810E-01 |
| Normal-vs-Age(81-100Yrs) |
3.464800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.422000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.386350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.399000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.073760E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.076100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.667000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.788000E-01 |
| Normal-VS-Type2 PRCC |
2.860000E-02 |
| Normal-VS-KIRP CIMP |
1.533190E-01 |
| Normal-VS-Unclassified PRCC |
3.532600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.873560E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.719410E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.936400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.610100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.324300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.568240E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.784200E-02 |
| Normal-vs-N1 |
4.048000E-01 |
| Normal-vs-N2 |
5.671800E-01 |
| N0-vs-N1 |
1.639920E-02 |
| N0-vs-N2 |
4.670600E-01 |
| N1-vs-N2 |
6.210800E-01 |
|
|
